Company Monitoring Page for Incyte

latest headlines for company on cafepharma

The Wait Goes On At YM Biosciences
Seeking Alpha
Wed, 09/5/12 - 10:41 am
Tags:
YM BioSciences, Incyte, Sanofi, JNJ, Novartis, CYT387
Why Incyte Could Be Headed Even Higher
Motley Fool
Sun, 07/15/12 - 11:27 am
Tags:
Incyte
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Sun, 07/15/12 - 11:22 am
Tags:
Alkermes, Medivation, Cubist Pharmaceuticals, Ariad Pharmaceuticals, Questcor Pharmaceuticals, Arena Pharmaceuticals, Seattle Genetics, Incyte, United Therapeutics, Amarin, ONYX Pharmaceuticals, Pharmacyclics, Human Genome Sciences, Theravance
Incyte Corp Ltd (INCY): Today's Featured Health Care Winner
The Steet
Sat, 07/7/12 - 11:25 am
Tags:
Incyte
Eli Lilly: A Long-Term Growth Stock
Seeking Alpha
Mon, 07/2/12 - 10:42 am
Tags:
Eli Lilly, diabetes, Bristol-Myers Squibb, Incyte, Merck, Sanofi, Novo Nordisk
Eli Lilly: New Drug Shows Strong Potential
Seeking Alpha
Fri, 06/22/12 - 09:28 am
Tags:
Eli Lilly, Incyte, baricitinib, Merck, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, rheumatoid arthritis
New Diabetes Drugs May Push Eli Lilly Higher By 2013
Seeking Alpha
Thu, 06/21/12 - 07:39 am
Tags:
diabetes, Eli Lilly, Astra Zeneca, Bristol-Myers Squibb, Incyte, linagliptin, Novo Nordisk, JNJ, empagliflozin, Boehringer Ingelheim
Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor
PharmPro
Sat, 06/9/12 - 04:54 pm
Tags:
Eli Lilly, Incyte, LY3009104, baricitinib, rheumatoid arthritis
Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
Yahoo
Fri, 06/8/12 - 01:28 pm
Tags:
Incyte, JAK inhibitors, baricitinib, Eli Lilly, rheumatoid arthritis
Cell Therapeutics' JAK2 Inhibitor Acquisition Is A Smart Pick-Up
Seeking Alpha
Tue, 05/29/12 - 05:09 pm
Tags:
Cell Therapeutics, JAK inhibitors, Novartis, Pfizer, Onyx, Incyte, pacritinib
Investing 101: Biotech Stocks With Insider Buying
Motley Fool
Sat, 05/19/12 - 12:11 pm
Tags:
Incyte, ViroPharma, Halozyme, Ziopharm, QLT Inc
Incyte's Potential Blockbuster Pipeline Asset Makes It An Attractive Takeover Target
Seeking Alpha
Wed, 05/16/12 - 12:20 pm
Tags:
Incyte, Pfizer, M&A
Incyte looks to ride on drug's success
The News Journal, DE
Sun, 05/6/12 - 11:44 am
Tags:
Incyte, Jakafi, myelofibrosis, polycythemia
YM Biosciences: The Next Way To Get Long Myelofibrosis
Seeking Alpha
Thu, 05/3/12 - 10:58 am
Tags:
YM BioSciences, myelofibrosis, Novartis, Eli Lilly, Incyte, CYT387
Pfizer and its Competition in 2012
Motley Fool
Thu, 04/12/12 - 11:26 am
Tags:
Pfizer, bapineuzumab, solanezumab, Eli Lilly, tofacitinib, Vertex Pharmaceuticals, Incyte
Targacept and Incyte Corporation -- Strong Performers in Strengthening Biotechnology Industry
Yahoo/MarketWire
Sat, 03/24/12 - 11:20 am
Tags:
Targacept, Incyte
7 Biotech Stocks Being Snapped Up By Insiders
Seeking Alpha
Sat, 03/17/12 - 10:46 am
Tags:
Agenus, China Biologic, Halozyme, Incyte, NuPathe, QLT, Seattle Genetics
Incyte Shares Decline After Fourth-Quarter Earnings
Bloomberg
Wed, 02/15/12 - 01:29 pm
Tags:
earnings, Incyte
Incyte in Neutral Lane
Yahoo/Zacks
Sat, 02/11/12 - 12:33 pm
Tags:
Incyte
10 Biotech Stocks With Strong Corporate Governance
Seeking Alpha
Wed, 01/18/12 - 10:03 am
Tags:
Amgen, Achillion, Chelsea Therapeutics, Charles River Laboratories, Indenix, Human Genome Sciences, Incyte, Immunogen, NPS Pharmaceuticals, PDL Biopharma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.